Contrasting Rockwell Medical (NASDAQ:RMTI) & MariMed (OTCMKTS:MRMD)

Rockwell Medical (NASDAQ:RMTIGet Free Report) and MariMed (OTCMKTS:MRMDGet Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings and dividends.

Volatility and Risk

Rockwell Medical has a beta of 1.7, indicating that its share price is 70% more volatile than the S&P 500. Comparatively, MariMed has a beta of 1.15, indicating that its share price is 15% more volatile than the S&P 500.

Institutional & Insider Ownership

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 0.2% of MariMed shares are held by institutional investors. 3.6% of Rockwell Medical shares are held by insiders. Comparatively, 19.0% of MariMed shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Rockwell Medical and MariMed, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical 1 0 1 0 2.00
MariMed 0 2 0 0 2.00

Rockwell Medical currently has a consensus price target of $2.00, suggesting a potential upside of 112.77%. Given Rockwell Medical’s higher possible upside, analysts clearly believe Rockwell Medical is more favorable than MariMed.

Profitability

This table compares Rockwell Medical and MariMed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Rockwell Medical -7.67% -15.64% -9.61%
MariMed -8.94% -5.85% -1.58%

Earnings & Valuation

This table compares Rockwell Medical and MariMed”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Rockwell Medical $69.26 million 0.53 -$5.31 million ($0.15) -6.27
MariMed $159.83 million 0.17 -$14.48 million ($0.03) -2.25

Rockwell Medical has higher earnings, but lower revenue than MariMed. Rockwell Medical is trading at a lower price-to-earnings ratio than MariMed, indicating that it is currently the more affordable of the two stocks.

Summary

Rockwell Medical beats MariMed on 7 of the 13 factors compared between the two stocks.

About Rockwell Medical

(Get Free Report)

Rockwell Medical, Inc., together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including testing supplies, 5% acetic acid cleaning solution, 5% and 2% citric acid descaler, filtration salts, and other items used by hemodialysis providers. The company's hemodialysis concentrate products are used to sustain patient's life by removing toxins and balancing electrolytes in a dialysis patient's bloodstream. The company serves to hemodialysis clinics. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.

About MariMed

(Get Free Report)

MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature’s Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby’s Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty’s Eddies brand and ice creams under Emack & Bolio’s brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.

Receive News & Ratings for Rockwell Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical and related companies with MarketBeat.com's FREE daily email newsletter.